Saved in:
| Main Authors: | Zhou, Yifan, Liang, Yan Shing, Wong, Yew Kee, Qiu, Haichuan, Wu, Yu Xi, He, Bin |
|---|---|
| Format: | Preprint |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2308.08561 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Quantum Long Short-Term Memory for Drug Discovery
by: Zhang, Liang, et al.
Published: (2024)
by: Zhang, Liang, et al.
Published: (2024)
Quantum-machine-assisted Drug Discovery
by: Zhou, Yidong, et al.
Published: (2024)
by: Zhou, Yidong, et al.
Published: (2024)
Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery
by: Jain, Prateek, et al.
Published: (2022)
by: Jain, Prateek, et al.
Published: (2022)
DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
by: Li, Kun, et al.
Published: (2025)
by: Li, Kun, et al.
Published: (2025)
Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
by: Chen, Dong, et al.
Published: (2025)
by: Chen, Dong, et al.
Published: (2025)
Machine Learning-Driven Enzyme Mining: Opportunities, Challenges, and Future Perspectives
by: Zhang, Yanzi, et al.
Published: (2025)
by: Zhang, Yanzi, et al.
Published: (2025)
AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing
by: Bilokon, Oleksandr, et al.
Published: (2024)
by: Bilokon, Oleksandr, et al.
Published: (2024)
Integrating Protein Dynamics into Structure-Based Drug Design via Full-Atom Stochastic Flows
by: Zhou, Xiangxin, et al.
Published: (2025)
by: Zhou, Xiangxin, et al.
Published: (2025)
Graph Neural Networks in Modern AI-aided Drug Discovery
by: Zhang, Odin, et al.
Published: (2025)
by: Zhang, Odin, et al.
Published: (2025)
MolCRAFT: Structure-Based Drug Design in Continuous Parameter Space
by: Qu, Yanru, et al.
Published: (2024)
by: Qu, Yanru, et al.
Published: (2024)
A Generalist Cross-Domain Molecular Learning Framework for Structure-Based Drug Discovery
by: Zhu, Yiheng, et al.
Published: (2025)
by: Zhu, Yiheng, et al.
Published: (2025)
Systems-Structure-Based Drug Design
by: Zaballa, Vincent D., et al.
Published: (2024)
by: Zaballa, Vincent D., et al.
Published: (2024)
Discrimination vs. Generation: The Machine Learning Dichotomy for Dopaminergic Hit Discovery
by: Sobodu, Temitope, et al.
Published: (2024)
by: Sobodu, Temitope, et al.
Published: (2024)
Quantum-inspired Reinforcement Learning for Synthesizable Drug Design
by: Wang, Dannong, et al.
Published: (2024)
by: Wang, Dannong, et al.
Published: (2024)
Conditional Chemical Language Models are Versatile Tools in Drug Discovery
by: Zhu, Lu, et al.
Published: (2025)
by: Zhu, Lu, et al.
Published: (2025)
How Evaluation Choices Distort the Outcome of Generative Drug Discovery
by: Özçelik, Rıza, et al.
Published: (2024)
by: Özçelik, Rıza, et al.
Published: (2024)
Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design
by: He, Yi, et al.
Published: (2025)
by: He, Yi, et al.
Published: (2025)
MP2D: Constrained Monte Carlo Tree-Guided Diffusion for Multi-Objective Protein Sequence Design
by: Kong, Zitai, et al.
Published: (2026)
by: Kong, Zitai, et al.
Published: (2026)
Graph-structured Small Molecule Drug Discovery Through Deep Learning: Progress, Challenges, and Opportunities
by: Li, Kun, et al.
Published: (2025)
by: Li, Kun, et al.
Published: (2025)
DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design
by: Guan, Jiaqi, et al.
Published: (2024)
by: Guan, Jiaqi, et al.
Published: (2024)
A Foundation Chemical Language Model for Comprehensive Fragment-Based Drug Discovery
by: Ho, Alexander, et al.
Published: (2025)
by: Ho, Alexander, et al.
Published: (2025)
Computational Explorations in Biomedicine: Unraveling Molecular Dynamics for Cancer, Drug Delivery, and Biomolecular Insights using LAMMPS Simulations
by: Bozorgpour, Reza
Published: (2023)
by: Bozorgpour, Reza
Published: (2023)
Contrastive Multi-Task Learning with Solvent-Aware Augmentation for Drug Discovery
by: Lan, Jing, et al.
Published: (2025)
by: Lan, Jing, et al.
Published: (2025)
FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling
by: Zhang, Zaixi, et al.
Published: (2024)
by: Zhang, Zaixi, et al.
Published: (2024)
Decomposed Direct Preference Optimization for Structure-Based Drug Design
by: Cheng, Xiwei, et al.
Published: (2024)
by: Cheng, Xiwei, et al.
Published: (2024)
CovDocker: Benchmarking Covalent Drug Design with Tasks, Datasets, and Solutions
by: Peng, Yangzhe, et al.
Published: (2025)
by: Peng, Yangzhe, et al.
Published: (2025)
Discovery of novel antimicrobial peptides with notable antibacterial potency by a LLM-based foundation model
by: Wang, Jike, et al.
Published: (2024)
by: Wang, Jike, et al.
Published: (2024)
Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery
by: Lan, Jing, et al.
Published: (2025)
by: Lan, Jing, et al.
Published: (2025)
Pushing the boundaries of Structure-Based Drug Design through Collaboration with Large Language Models
by: Gao, Bowen, et al.
Published: (2025)
by: Gao, Bowen, et al.
Published: (2025)
Piloting Structure-Based Drug Design via Modality-Specific Optimal Schedule
by: Qiu, Keyue, et al.
Published: (2025)
by: Qiu, Keyue, et al.
Published: (2025)
InstructMol: Multi-Modal Integration for Building a Versatile and Reliable Molecular Assistant in Drug Discovery
by: Cao, He, et al.
Published: (2023)
by: Cao, He, et al.
Published: (2023)
Binding-Adaptive Diffusion Models for Structure-Based Drug Design
by: Huang, Zhilin, et al.
Published: (2024)
by: Huang, Zhilin, et al.
Published: (2024)
Reprogramming Pretrained Target-Specific Diffusion Models for Dual-Target Drug Design
by: Zhou, Xiangxin, et al.
Published: (2024)
by: Zhou, Xiangxin, et al.
Published: (2024)
Fragment and Geometry Aware Tokenization of Molecules for Structure-Based Drug Design Using Language Models
by: Fu, Cong, et al.
Published: (2024)
by: Fu, Cong, et al.
Published: (2024)
CardioGenAI: A Machine Learning-Based Framework for Re-Engineering Drugs for Reduced hERG Liability
by: Kyro, Gregory W., et al.
Published: (2024)
by: Kyro, Gregory W., et al.
Published: (2024)
Rethinking Drug-Drug Interaction Modeling as Generalizable Relation Learning
by: Xu, Dong, et al.
Published: (2026)
by: Xu, Dong, et al.
Published: (2026)
PKAG-DDI: Pairwise Knowledge-Augmented Language Model for Drug-Drug Interaction Event Text Generation
by: Wang, Ziyan, et al.
Published: (2025)
by: Wang, Ziyan, et al.
Published: (2025)
Interpretable QSPR Modeling using Recursive Feature Machines and Multi-scale Fingerprints
by: Shen, Jiaxuan, et al.
Published: (2024)
by: Shen, Jiaxuan, et al.
Published: (2024)
IntFold: A Controllable Foundation Model for General and Specialized Biomolecular Structure Prediction
by: The IntFold Team, et al.
Published: (2025)
by: The IntFold Team, et al.
Published: (2025)
Reverse Degree-Based Topological Indices and QSPR Analysis of Cancer Drugs
by: Nagesh, H. M.
Published: (2024)
by: Nagesh, H. M.
Published: (2024)
Similar Items
-
Quantum Long Short-Term Memory for Drug Discovery
by: Zhang, Liang, et al.
Published: (2024) -
Quantum-machine-assisted Drug Discovery
by: Zhou, Yidong, et al.
Published: (2024) -
Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery
by: Jain, Prateek, et al.
Published: (2022) -
DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
by: Li, Kun, et al.
Published: (2025) -
Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
by: Chen, Dong, et al.
Published: (2025)